Managing Director and Senior Biotechnology Analyst Jason Kolbert of the Maxim Group has staked out a select group of nascent cell therapy companies positioned to reap huge gains for investors willing to diversify.

Warner Chilcott plc (NASDAQ: WCRX) traded at $18.5, down -4.1 percent during Pre Market on 18,110 shares. The company's relative strength index was at 90.61 which shows ... Mitsubishi UFJ Financial Group Inc. (NYSE: MTU) traded at $7, down -3.8 percent ...

(DDD, $38.21, +$2.44, +6.82%) reported first-quarter revenue that slightly exceeded expectations and a profit in line with consensus, while gross margin expanded.

After reporting solid earnings last week, Icon PLC (ICLR) rose 3% in fast trade. The company, featured in IBD's New America in March, is a contract research ... 3D Systems (DDD) remained in rally mode after recently finding support at its 40-week ...

3D Systems (NYSE: DDD) had its target price raised by Needham & Company from $40.00 to $42.00. The firm currently has ... Grainger plc (LON: GRI) had its target price increased by Jefferies Group from GBX 148 ($2.29) to GBX 162 ($2.51). Jefferies Group ...